A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 25,774 shares of ACLX stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,774
Previous 22,755 13.27%
Holding current value
$2.27 Million
Previous $1.26 Million 71.47%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$50.91 - $86.61 $153,697 - $261,475
3,019 Added 13.27%
25,774 $2.15 Million
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $1.13 Million - $1.52 Million
22,755 New
22,755 $1.26 Million

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.86B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.